Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Bezirkskliniken Schwaben KU Anstalt des offentlichen Rechts des Bezirks Schwaben

Research site

Germany Geschwister-Schoenert-Strasse 1, Kriegshaber, 86156 Augsburg, Germany

  • 3 trials recruiting
  • Schizophrenia · Borderline personality disorder · Depression
  • Adult patients

About Specializations

Bezirkskliniken Schwaben KU Anstalt des offentlichen Rechts des Bezirks Schwaben in Augsburg, Germany specialises in clinical trials of conditions such as Schizophrenia, Borderline personality disorder, Depression, Schizoaffective disorder, and other specialisations. This site conducts important research.

Main research areas of the site

Neuropsychiatry

The medical center is at the forefront of neuropsychiatry, focusing on innovative treatments for cognitive dysfunction in schizophrenia. By integrating pharmacological and physical interventions, the center aims to enhance cognitive function and overall quality of life for patients.

  • Myelin Plasticity
  • Cognitive Dysfunction
  • Global Assessment of Functioning

Through pioneering research, the center explores the synergistic effects of combining clemastine with aerobic exercise, targeting myelin plasticity to improve cognitive outcomes in schizophrenia patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Geschwister-Schoenert-Strasse 1, Kriegshaber86156 AugsburgGermany
Open in maps ↗
Recruiting now
3 trials
Conditions studied
5

More sites in AugsburgGermany

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

5 clinical trials

Depression

Recruiting

Testing dehydroepiandrosterone combined with standard antidepressants for patients with treatment-resistant depression

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lactose Monohydrate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Schizophrenia

Recruiting

Study on Clemastine and Aerobic Exercise for Improving Cognitive Function in Schizophrenia Patients

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Clemastine
  • Sponsor:Klinikum der Universitaet Muenchen AöR

Schizoaffective disorder+2

Recruiting

Study on the Effect of Clozapine and Drug Combination for Patients with Schizophrenia Experiencing First-Line Treatment Failure

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Amisulpride
  • Sponsor:Universitair Medisch Centrum Utrecht

Borderline personality disorder

Not yet recruiting

A study to evaluate the effectiveness and safety of AP707 in patients with borderline personality disorder.

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Adezunap
  • Sponsor:Apurano Pharmaceuticals GmbH

A study to evaluate the effect of xanomeline tartrate and trospium chloride on cognitive impairment in adults with schizophrenia.

Not yet recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:European Group for Research in Schizophrenia Stichting
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.